What is the catalog number for Prokineticin 1/PROK1 Rabbit Polyclonal Antibody?

The catalog number for Prokineticin 1/PROK1 Rabbit Polyclonal Antibody is orb334614.

What sizes are available for Prokineticin 1/PROK1 Rabbit Polyclonal Antibody?

Prokineticin 1/PROK1 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Prokineticin 1/PROK1 Rabbit Polyclonal Antibody in stock?

Prokineticin 1/PROK1 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Prokineticin 1/PROK1 Rabbit Polyclonal Antibody

Anti-Prokineticin 1/PROK1 Antibody. Tested in ELISA, WB applications. This antibody reacts with Human.

Product Specifications

Product Name Alternative

Prokineticin-1; Endocrine-gland-derived vascular endothelial growth factor; EG-VEGF; Mambakine; PROK1; UNQ600/PRO1186

UniProt

P58294

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins.

Immunogen

E. coli-derived human Prokineticin 1 recombinant protein (Position: A20-F105) . Human Prokineticin 1 shares 88.4% and 91.9% amino acid (aa) sequence identity with mouse and rat Prokineticin 1, respectively.

Target

Prokineticin-1

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cardiovascular Research, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

ELISA, 0.1-0.5μg/ml, - Western blot, 0.1-0.5μg/ml, Human

Form

Lyophilized

Molecular Weight

20 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

ELISA, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.